InVitro International (IVRO)

USD 0.1

(15.93%)

Total Liabilities Summary of InVitro International

  • InVitro International's latest annual total liabilities in 2023 was 78.99 Thousand USD , up 15.76% from previous year.
  • InVitro International's latest quarterly total liabilities in 2024 Q1 was 67.74 Thousand USD , down -14.24% from previous quarter.
  • InVitro International reported annual total liabilities of 68.23 Thousand USD in 2022, down -66.15% from previous year.
  • InVitro International reported annual total liabilities of 201.61 Thousand USD in 2021, down -4.97% from previous year.
  • InVitro International reported quarterly total liabilities of 51.57 Thousand USD for 2024 Q3, down -6.23% from previous quarter.
  • InVitro International reported quarterly total liabilities of 55 Thousand USD for 2024 Q2, down -18.81% from previous quarter.

Annual Total Liabilities Chart of InVitro International (2023 - 1990)

Historical Annual Total Liabilities of InVitro International (2023 - 1990)

Year Total Liabilities Total Liabilities Growth
2023 78.99 Thousand USD 15.76%
2022 68.23 Thousand USD -66.15%
2021 201.61 Thousand USD -4.97%
2020 212.16 Thousand USD 37.7%
2019 154.07 Thousand USD 114.91%
2018 71.69 Thousand USD -3.27%
2017 74.11 Thousand USD -3.72%
2016 76.97 Thousand USD -4.06%
2015 80.23 Thousand USD 0.0%
1996 400 Thousand USD 0.0%
1995 400 Thousand USD -55.56%
1994 900 Thousand USD 12.5%
1993 800 Thousand USD -27.27%
1992 1.1 Million USD 266.67%
1991 300 Thousand USD -84.21%
1990 1.9 Million USD 0.0%

Peer Total Liabilities Comparison of InVitro International

Name Total Liabilities Total Liabilities Difference
American Bio Medica Corporation 3.6 Million USD 97.811%
Arrayit Corporation 7.49 Million USD 98.946%
Atlantic International Corp. 3.82 Million USD 97.937%
Biocept, Inc. 22.01 Million USD 99.641%
Bioqual, Inc. 18.93 Million USD 99.583%
CardioGenics Holdings Inc 1.79 Million USD 95.599%
DermTech, Inc. 64.75 Million USD 99.878%
Global WholeHealth Partners Corporation - USD -Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 734.97 Million USD 99.989%
HTG Molecular Diagnostics, Inc. 12.38 Million USD 99.362%
iMD Companies, Inc. 1.67 Million USD 95.282%
IDenta Corp. 1.01 Million USD 92.204%
Interpace Biosciences, Inc. 28.15 Million USD 99.719%
Integrative Health Technologies, Inc. 297.94 Thousand USD 73.489%
Lumos Diagnostics Holdings Limited 19.72 Million USD 99.6%
Many Bright Ideas Technologies Inc. 129.29 Thousand USD 38.908%
Medical Imaging Corp. 9.51 Million USD 99.17%
NovelStem International Corp. 4.2 Million USD 98.122%
Optigenex Inc. 9.57 Million USD 99.175%
PharmChem, Inc. 558.64 Thousand USD 85.86%
Proteome Sciences plc 18.48 Million USD 99.573%
Response Genetics, Inc 15.86 Million USD 99.502%
Rennova Health, Inc. 49.66 Million USD 99.841%
RushNet, Inc. 6.23 Million USD 98.734%
ScreenPro Security Inc. 1.6 Million USD 95.065%
Stella Diagnostics Inc. 18 Million USD 99.561%
StageZero Life Sciences Ltd. 8.2 Million USD 99.037%
Todos Medical Ltd. 50.15 Million USD 99.843%